-
1
-
-
46249112085
-
Combinatorial patterns of histone acetylations and methylations in the human genome
-
COI: 1:CAS:528:DC%2BD1cXnslKktL0%3D, PID: 18552846
-
Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet. 2008;40(7):897–903. doi:10.1038/ng.154.
-
(2008)
Nat Genet
, vol.40
, Issue.7
, pp. 897-903
-
-
Wang, Z.1
Zang, C.2
Rosenfeld, J.A.3
Schones, D.E.4
Barski, A.5
Cuddapah, S.6
-
2
-
-
77956898565
-
Recent advances in histone deacetylase targeted cancer therapy
-
COI: 1:CAS:528:DC%2BC3cXhtVymtLnL, PID: 20740342
-
Hoshino I, Matsubara H. Recent advances in histone deacetylase targeted cancer therapy. Surg Today. 2010;40(9):809–15. doi:10.1007/s00595-010-4300-6.
-
(2010)
Surg Today
, vol.40
, Issue.9
, pp. 809-815
-
-
Hoshino, I.1
Matsubara, H.2
-
3
-
-
0037154963
-
Cooperation between complexes that regulate chromatin structure and transcription
-
COI: 1:CAS:528:DC%2BD38XhvF2jsrs%3D, PID: 11909519
-
Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell. 2002;108(4):475–87.
-
(2002)
Cell
, vol.108
, Issue.4
, pp. 475-487
-
-
Narlikar, G.J.1
Fan, H.Y.2
Kingston, R.E.3
-
4
-
-
54049093249
-
Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review)
-
COI: 1:CAS:528:DC%2BD1cXht1KhtbnP, PID: 18813776
-
Emanuele S, Lauricella M, Tesoriere G. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review). Int J Oncol. 2008;33(4):637–46.
-
(2008)
Int J Oncol
, vol.33
, Issue.4
, pp. 637-646
-
-
Emanuele, S.1
Lauricella, M.2
Tesoriere, G.3
-
5
-
-
30344477367
-
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
-
COI: 1:CAS:528:DC%2BD28Xht1GgsA%3D%3D, PID: 16397526
-
Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer. 2006;6(1):38–51. doi:10.1038/nrc1779.
-
(2006)
Nat Rev Cancer
, vol.6
, Issue.1
, pp. 38-51
-
-
Minucci, S.1
Pelicci, P.G.2
-
6
-
-
23944469429
-
Synergistic apoptosis induction by proteasome and histone deacetylase inhibitors is dependent on protein synthesis
-
COI: 1:CAS:528:DC%2BD2MXotFentb0%3D, PID: 16133866
-
Drexler HC, Euler M. Synergistic apoptosis induction by proteasome and histone deacetylase inhibitors is dependent on protein synthesis. Apoptosis. 2005;10(4):743–58. doi:10.1007/s10495-005-2942-4.
-
(2005)
Apoptosis
, vol.10
, Issue.4
, pp. 743-758
-
-
Drexler, H.C.1
Euler, M.2
-
7
-
-
42249098495
-
Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics
-
COI: 1:CAS:528:DC%2BD1cXks1Gms78%3D, PID: 18413789
-
Hadnagy A, Beaulieu R, Balicki D. Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics. Mol Cancer Ther. 2008;7(4):740–8. doi:10.1158/1535-7163.mct-07-2284.
-
(2008)
Mol Cancer Ther
, vol.7
, Issue.4
, pp. 740-748
-
-
Hadnagy, A.1
Beaulieu, R.2
Balicki, D.3
-
8
-
-
2542523228
-
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors
-
COI: 1:CAS:528:DC%2BD2cXksVKnt7g%3D, PID: 15173093
-
Pei XY, Dai Y, Grant S. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Clin Cancer Res. 2004;10(11):3839–52. doi:10.1158/1078-0432.ccr-03-0561.
-
(2004)
Clin Cancer Res
, vol.10
, Issue.11
, pp. 3839-3852
-
-
Pei, X.Y.1
Dai, Y.2
Grant, S.3
-
9
-
-
0242493856
-
The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571
-
COI: 1:CAS:528:DC%2BD3sXptVymtb0%3D, PID: 12893773
-
Yu C, Rahmani M, Conrad D, Subler M, Dent P, Grant S. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571. Blood. 2003;102(10):3765–74. doi:10.1182/blood-2003-03-0737.
-
(2003)
Blood
, vol.102
, Issue.10
, pp. 3765-3774
-
-
Yu, C.1
Rahmani, M.2
Conrad, D.3
Subler, M.4
Dent, P.5
Grant, S.6
-
10
-
-
23244459828
-
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma
-
COI: 1:CAS:528:DC%2BD2MXps1CntL4%3D, PID: 16026644
-
Fandy TE, Shankar S, Ross DD, Sausville E, Srivastava RK. Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma. Neoplasia. 2005;7(7):646–57.
-
(2005)
Neoplasia
, vol.7
, Issue.7
, pp. 646-657
-
-
Fandy, T.E.1
Shankar, S.2
Ross, D.D.3
Sausville, E.4
Srivastava, R.K.5
-
11
-
-
34250689152
-
Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells
-
COI: 1:CAS:528:DC%2BD2sXlsVWhur0%3D, PID: 17464248
-
Bar-Sela G, Jacobs KM, Gius D. Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells. Cancer J. 2007;13(1):65–9. doi:10.1097/PPO.0b013e31803c7565.
-
(2007)
Cancer J
, vol.13
, Issue.1
, pp. 65-69
-
-
Bar-Sela, G.1
Jacobs, K.M.2
Gius, D.3
-
12
-
-
77956413585
-
Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy
-
COI: 1:CAS:528:DC%2BC3cXhtVyru7bI, PID: 20679890
-
Jazirehi AR. Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy. Anticancer Drugs. 2010;21(9):805–13. doi:10.1097/CAD.0b013e32833dad91.
-
(2010)
Anticancer Drugs
, vol.21
, Issue.9
, pp. 805-813
-
-
Jazirehi, A.R.1
-
13
-
-
0345275879
-
Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines
-
COI: 1:CAS:528:DC%2BD3sXptFOlsrk%3D, PID: 14633667
-
Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, et al. Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003;63(22):7563–70.
-
(2003)
Cancer Res
, vol.63
, Issue.22
, pp. 7563-7570
-
-
Fang, M.Z.1
Wang, Y.2
Ai, N.3
Hou, Z.4
Sun, Y.5
Lu, H.6
-
14
-
-
84902551030
-
(−)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA/p75NTR signaling in APP/PS1 transgenic mice
-
COI: 1:CAS:528:DC%2BC3sXhvFKgsrjP, PID: 24356899
-
Liu M, Chen F, Sha L, Wang S, Tao L, Yao L, et al. (−)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA/p75NTR signaling in APP/PS1 transgenic mice. Mol Neurobiol. 2014;49(3):1350–63. doi:10.1007/s12035-013-8608-2.
-
(2014)
Mol Neurobiol
, vol.49
, Issue.3
, pp. 1350-1363
-
-
Liu, M.1
Chen, F.2
Sha, L.3
Wang, S.4
Tao, L.5
Yao, L.6
-
15
-
-
84866269044
-
Green tea (−)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia
-
COI: 1:CAS:528:DC%2BC38XhsFGjtrfK, PID: 22964138
-
Biasibetti R, Tramontina AC, Costa AP, Dutra MF, Quincozes-Santos A, Nardin P, et al. Green tea (−)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia. Behav Brain Res. 2013;236(1):186–93. doi:10.1016/j.bbr.2012.08.039.
-
(2013)
Behav Brain Res
, vol.236
, Issue.1
, pp. 186-193
-
-
Biasibetti, R.1
Tramontina, A.C.2
Costa, A.P.3
Dutra, M.F.4
Quincozes-Santos, A.5
Nardin, P.6
-
16
-
-
25444500410
-
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice
-
COI: 1:CAS:528:DC%2BD2MXhtVGls73F, PID: 16177050
-
Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci. 2005;25(38):8807–14. doi:10.1523/jneurosci.1521-05.2005.
-
(2005)
J Neurosci
, vol.25
, Issue.38
, pp. 8807-8814
-
-
Rezai-Zadeh, K.1
Shytle, D.2
Sun, N.3
Mori, T.4
Hou, H.5
Jeanniton, D.6
-
17
-
-
0034094214
-
Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene
-
COI: 1:STN:280:DC%2BD3czivVWntA%3D%3D, PID: 10867787
-
Murrell JR, Hake AM, Quaid KA, Farlow MR, Ghetti B. Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene. Arch Neurol. 2000;57(6):885–7.
-
(2000)
Arch Neurol
, vol.57
, Issue.6
, pp. 885-887
-
-
Murrell, J.R.1
Hake, A.M.2
Quaid, K.A.3
Farlow, M.R.4
Ghetti, B.5
-
18
-
-
0025950987
-
A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease
-
COI: 1:CAS:528:DyaK38Xls1ykurg%3D, PID: 1925564
-
Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science. 1991;254(5028):97–9.
-
(1991)
Science
, vol.254
, Issue.5028
, pp. 97-99
-
-
Murrell, J.1
Farlow, M.2
Ghetti, B.3
Benson, M.D.4
-
19
-
-
77951093230
-
Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein
-
COI: 1:CAS:528:DC%2BC3cXkvVSru7o%3D, PID: 19759550
-
Botelho MG, Wang X, Arndt-Jovin DJ, Becker D, Jovin TM. Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein. J Invest Dermatol. 2010;130(5):1400–10. doi:10.1038/jid.2009.296.
-
(2010)
J Invest Dermatol.
, vol.130
, Issue.5
, pp. 1400-1410
-
-
Botelho, M.G.1
Wang, X.2
Arndt-Jovin, D.J.3
Becker, D.4
Jovin, T.M.5
-
20
-
-
0242442605
-
Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation
-
COI: 1:CAS:528:DC%2BD3sXovVGls7k%3D, PID: 14612490
-
Hansel DE, Rahman A, Wehner S, Herzog V, Yeo CJ, Maitra A. Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation. Cancer Res. 2003;63(21):7032–7.
-
(2003)
Cancer Res
, vol.63
, Issue.21
, pp. 7032-7037
-
-
Hansel, D.E.1
Rahman, A.2
Wehner, S.3
Herzog, V.4
Yeo, C.J.5
Maitra, A.6
-
21
-
-
0035313986
-
Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo
-
COI: 1:CAS:528:DC%2BD3MXitVGqt70%3D, PID: 11279603
-
Meng JY, Kataoka H, Itoh H, Koono M. Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. Int J Cancer. 2001;92(1):31–9.
-
(2001)
Int J Cancer
, vol.92
, Issue.1
, pp. 31-39
-
-
Meng, J.Y.1
Kataoka, H.2
Itoh, H.3
Koono, M.4
-
22
-
-
58249094850
-
Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth
-
COI: 1:CAS:528:DC%2BD1MXmvFek, PID: 19117996
-
Takayama K, Tsutsumi S, Suzuki T, Horie-Inoue K, Ikeda K, Kaneshiro K, et al. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Cancer Res. 2009;69(1):137–42. doi:10.1158/0008-5472.can-08-3633.
-
(2009)
Cancer Res
, vol.69
, Issue.1
, pp. 137-142
-
-
Takayama, K.1
Tsutsumi, S.2
Suzuki, T.3
Horie-Inoue, K.4
Ikeda, K.5
Kaneshiro, K.6
-
23
-
-
34249033596
-
Altered cholesterol metabolism in APP695-transfected neuroblastoma cells
-
COI: 1:CAS:528:DC%2BD2sXlvVyjurc%3D, PID: 17428449
-
Wirths O, Thelen KM, Lutjohann D, Falkai P, Bayer TA. Altered cholesterol metabolism in APP695-transfected neuroblastoma cells. Brain Res. 2007;1152:209–14. doi:10.1016/j.brainres.2007.03.029.
-
(2007)
Brain Res
, vol.1152
, pp. 209-214
-
-
Wirths, O.1
Thelen, K.M.2
Lutjohann, D.3
Falkai, P.4
Bayer, T.A.5
-
24
-
-
0032539666
-
From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells
-
COI: 1:CAS:528:DyaK1cXht1Wqu7o%3D, PID: 9465092
-
Pietrzik CU, Hoffmann J, Stober K, Chen CY, Bauer C, Otero DA, et al. From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells. Proc Natl Acad Sci USA. 1998;95(4):1770–5.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, Issue.4
, pp. 1770-1775
-
-
Pietrzik, C.U.1
Hoffmann, J.2
Stober, K.3
Chen, C.Y.4
Bauer, C.5
Otero, D.A.6
-
25
-
-
77951247066
-
Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein
-
COI: 1:CAS:528:DC%2BC3cXjvFaju7Y%3D, PID: 20145244
-
Venkataramani V, Rossner C, Iffland L, Schweyer S, Tamboli IY, Walter J, et al. Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein. J Biol Chem. 2010;285(14):10678–89. doi:10.1074/jbc.M109.057836.
-
(2010)
J Biol Chem
, vol.285
, Issue.14
, pp. 10678-10689
-
-
Venkataramani, V.1
Rossner, C.2
Iffland, L.3
Schweyer, S.4
Tamboli, I.Y.5
Walter, J.6
-
26
-
-
84888133742
-
Epigenetic changes in the progression of Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BC3sXhsV2nu7jJ, PID: 24012631
-
Bradley-Whitman MA, Lovell MA. Epigenetic changes in the progression of Alzheimer’s disease. Mech Ageing Dev. 2013;134(10):486–95. doi:10.1016/j.mad.2013.08.005.
-
(2013)
Mech Ageing Dev
, vol.134
, Issue.10
, pp. 486-495
-
-
Bradley-Whitman, M.A.1
Lovell, M.A.2
-
27
-
-
79958769568
-
Epigenetic mechanisms in Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BC3MXntlGjtrc%3D, PID: 21482442
-
Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic mechanisms in Alzheimer’s disease. Neurobiol Aging. 2011;32(7):1161–80. doi:10.1016/j.neurobiolaging.2010.08.017.
-
(2011)
Neurobiol Aging
, vol.32
, Issue.7
, pp. 1161-1180
-
-
Mastroeni, D.1
Grover, A.2
Delvaux, E.3
Whiteside, C.4
Coleman, P.D.5
Rogers, J.6
-
28
-
-
84862907481
-
Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis
-
COI: 1:CAS:528:DC%2BC3MXhsVSis77M, PID: 21707863
-
Xu Z, Fang S, Zuo Y, Zhang Y, Cheng R, Wang Q, et al. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis. Cancer Sci. 2011;102(10):1789–98. doi:10.1111/j.1349-7006.2011.02013.x.
-
(2011)
Cancer Sci
, vol.102
, Issue.10
, pp. 1789-1798
-
-
Xu, Z.1
Fang, S.2
Zuo, Y.3
Zhang, Y.4
Cheng, R.5
Wang, Q.6
-
29
-
-
84891098660
-
The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells
-
PID: 24236158
-
Chen S, Zhao Y, Gou WF, Zhao S, Takano Y, Zheng HC. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells. PLoS One. 2013;8(11):e79781. doi:10.1371/journal.pone.0079781.
-
(2013)
PLoS One
, vol.8
, Issue.11
, pp. e79781
-
-
Chen, S.1
Zhao, Y.2
Gou, W.F.3
Zhao, S.4
Takano, Y.5
Zheng, H.C.6
-
30
-
-
0027166048
-
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
-
COI: 1:CAS:528:DyaK3sXms1eqtbs%3D, PID: 8358790
-
Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74(4):609–19.
-
(1993)
Cell
, vol.74
, Issue.4
, pp. 609-619
-
-
Oltvai, Z.N.1
Milliman, C.L.2
Korsmeyer, S.J.3
-
31
-
-
77955645243
-
Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize
-
PID: 20718950
-
Yang F, Zhang L, Li J, Huang J, Wen R, Ma L, et al. Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize. BMC Plant Biol. 2010;10:178. doi:10.1186/1471-2229-10-178.
-
(2010)
BMC Plant Biol
, vol.10
, pp. 178
-
-
Yang, F.1
Zhang, L.2
Li, J.3
Huang, J.4
Wen, R.5
Ma, L.6
-
32
-
-
77955270739
-
β-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain
-
COI: 1:CAS:528:DC%2BC3cXpvVKnur4%3D, PID: 20561999
-
Buoso E, Lanni C, Schettini G, Govoni S, Racchi M. β-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain. Pharmacol Res. 2010;62(4):308–17. doi:10.1016/j.phrs.2010.05.002.
-
(2010)
Pharmacol Res
, vol.62
, Issue.4
, pp. 308-317
-
-
Buoso, E.1
Lanni, C.2
Schettini, G.3
Govoni, S.4
Racchi, M.5
-
33
-
-
15944413832
-
The non-amyloidogenic pathway: structure and function of α-secretases
-
COI: 1:CAS:528:DC%2BD2MXotFaktr4%3D, PID: 15709475
-
Kojro E, Fahrenholz F. The non-amyloidogenic pathway: structure and function of α-secretases. Subcell Biochem. 2005;38:105–27.
-
(2005)
Subcell Biochem
, vol.38
, pp. 105-127
-
-
Kojro, E.1
Fahrenholz, F.2
-
34
-
-
84655160766
-
Proteolytic processing of Alzheimer’s β-amyloid precursor protein
-
COI: 1:CAS:528:DC%2BC38XhsFynsrs%3D, PID: 22122372
-
Zhang H, Ma Q, Zhang YW, Xu H. Proteolytic processing of Alzheimer’s β-amyloid precursor protein. J Neurochem. 2012;120(Suppl 1):9–21. doi:10.1111/j.1471-4159.2011.07519.x.
-
(2012)
J Neurochem
, vol.120
, pp. 9-21
-
-
Zhang, H.1
Ma, Q.2
Zhang, Y.W.3
Xu, H.4
-
35
-
-
0001067847
-
Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues
-
COI: 1:CAS:528:DyaL1cXmt1Ohsr8%3D, PID: 3140239
-
Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC, et al. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA. 1988;85(19):7341–5.
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, Issue.19
, pp. 7341-7345
-
-
Selkoe, D.J.1
Podlisny, M.B.2
Joachim, C.L.3
Vickers, E.A.4
Lee, G.5
Fritz, L.C.6
-
36
-
-
4043072841
-
Increased expression of amyloid precursor protein in oral squamous cell carcinoma
-
COI: 1:CAS:528:DC%2BD2cXmvVenurg%3D, PID: 15252842
-
Ko SY, Lin SC, Chang KW, Wong YK, Liu CJ, Chi CW, et al. Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int J Cancer. 2004;111(5):727–32. doi:10.1002/ijc.20328.
-
(2004)
Int J Cancer
, vol.111
, Issue.5
, pp. 727-732
-
-
Ko, S.Y.1
Lin, S.C.2
Chang, K.W.3
Wong, Y.K.4
Liu, C.J.5
Chi, C.W.6
-
37
-
-
58349094740
-
Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation
-
COI: 1:CAS:528:DC%2BD1MXltFShtg%3D%3D, PID: 19147572
-
Choi KC, Jung MG, Lee YH, Yoon JC, Kwon SH, Kang HB, et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 2009;69(2):583–92. doi:10.1158/0008-5472.can-08-2442.
-
(2009)
Cancer Res
, vol.69
, Issue.2
, pp. 583-592
-
-
Choi, K.C.1
Jung, M.G.2
Lee, Y.H.3
Yoon, J.C.4
Kwon, S.H.5
Kang, H.B.6
-
38
-
-
84878720205
-
Plant polyphenols and oxidative metabolites of the herbal alkenylbenzene methyleugenol suppress histone deacetylase activity in human colon carcinoma cells
-
PID: 23476753
-
Groh IA, Chen C, Luske C, Cartus AT, Esselen M. Plant polyphenols and oxidative metabolites of the herbal alkenylbenzene methyleugenol suppress histone deacetylase activity in human colon carcinoma cells. J Nutr Metab. 2013;2013:821082. doi:10.1155/2013/821082.
-
(2013)
J Nutr Metab
, vol.2013
, pp. 821082
-
-
Groh, I.A.1
Chen, C.2
Luske, C.3
Cartus, A.T.4
Esselen, M.5
-
39
-
-
36049045474
-
Expression of HDAC1 and CBP/p300 in human colorectal carcinomas
-
COI: 1:CAS:528:DC%2BD2sXhsVelu7fO, PID: 17720775
-
Ishihama K, Yamakawa M, Semba S, Takeda H, Kawata S, Kimura S, et al. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas. J Clin Pathol. 2007;60(11):1205–10. doi:10.1136/jcp.2005.029165.
-
(2007)
J Clin Pathol
, vol.60
, Issue.11
, pp. 1205-1210
-
-
Ishihama, K.1
Yamakawa, M.2
Semba, S.3
Takeda, H.4
Kawata, S.5
Kimura, S.6
-
40
-
-
84878401588
-
HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure
-
COI: 1:CAS:528:DC%2BC3sXpsVKrsrs%3D, PID: 23724067
-
Stypula-Cyrus Y, Damania D, Kunte DP, Cruz MD, Subramanian H, Roy HK, et al. HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure. PLoS One. 2013;8(5):e64600. doi:10.1371/journal.pone.0064600.
-
(2013)
PLoS One
, vol.8
, Issue.5
, pp. e64600
-
-
Stypula-Cyrus, Y.1
Damania, D.2
Kunte, D.P.3
Cruz, M.D.4
Subramanian, H.5
Roy, H.K.6
-
41
-
-
80053506498
-
Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival
-
PID: 21457345
-
Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, et al. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J Oral Pathol Med. 2011;40(9):706–14. doi:10.1111/j.1600-0714.2011.01031.x.
-
(2011)
J Oral Pathol Med
, vol.40
, Issue.9
, pp. 706-714
-
-
Theocharis, S.1
Klijanienko, J.2
Giaginis, C.3
Rodriguez, J.4
Jouffroy, T.5
Girod, A.6
-
42
-
-
0035964743
-
Histone deacetylase and DNA methyltransferase in human prostate cancer
-
COI: 1:CAS:528:DC%2BD3MXmvV2jsb4%3D, PID: 11563853
-
Patra SK, Patra A, Dahiya R. Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem Biophys Res Commun. 2001;287(3):705–13. doi:10.1006/bbrc.2001.5639.
-
(2001)
Biochem Biophys Res Commun
, vol.287
, Issue.3
, pp. 705-713
-
-
Patra, S.K.1
Patra, A.2
Dahiya, R.3
-
43
-
-
77954146994
-
Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression
-
COI: 1:CAS:528:DC%2BC3cXns1Sks7Y%3D, PID: 20384633
-
Noro R, Miyanaga A, Minegishi Y, Okano T, Seike M, Soeno C, et al. Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression. Cancer Sci. 2010;101(6):1424–30. doi:10.1111/j.1349-7006.2010.01559.x.
-
(2010)
Cancer Sci
, vol.101
, Issue.6
, pp. 1424-1430
-
-
Noro, R.1
Miyanaga, A.2
Minegishi, Y.3
Okano, T.4
Seike, M.5
Soeno, C.6
-
44
-
-
33745320974
-
Targeting histone deacetylase in cancer therapy
-
COI: 1:CAS:528:DC%2BD28XntFaltrc%3D, PID: 16450343
-
Lin HY, Chen CS, Lin SP, Weng JR. Targeting histone deacetylase in cancer therapy. Med Res Rev. 2006;26(4):397–413. doi:10.1002/med.20056.
-
(2006)
Med Res Rev
, vol.26
, Issue.4
, pp. 397-413
-
-
Lin, H.Y.1
Chen, C.S.2
Lin, S.P.3
Weng, J.R.4
-
45
-
-
0023152686
-
Rat gene encoding the 78-kDa glucose-regulated protein GRP78: its regulatory sequences and the effect of protein glycosylation on its expression
-
COI: 1:CAS:528:DyaL2sXhtlaku7s%3D, PID: 3468506
-
Chang SC, Wooden SK, Nakaki T, Kim YK, Lin AY, Kung L, et al. Rat gene encoding the 78-kDa glucose-regulated protein GRP78: its regulatory sequences and the effect of protein glycosylation on its expression. Proc Natl Acad Sci USA. 1987;84(3):680–4.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, Issue.3
, pp. 680-684
-
-
Chang, S.C.1
Wooden, S.K.2
Nakaki, T.3
Kim, Y.K.4
Lin, A.Y.5
Kung, L.6
-
46
-
-
0032475957
-
The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Aβ40 and Aβ42 secretion
-
COI: 1:CAS:528:DyaK1cXms1egsrY%3D, PID: 9748217
-
Yang Y, Turner RS, Gaut JR. The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Aβ40 and Aβ42 secretion. J Biol Chem. 1998;273(40):25552–5.
-
(1998)
J Biol Chem
, vol.273
, Issue.40
, pp. 25552-25555
-
-
Yang, Y.1
Turner, R.S.2
Gaut, J.R.3
|